Wholesaler and trader of pharmaceutical injections, tablets, and capsules.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors - Brand Intelligence

About Denexopharma

Denexopharma is a company based in India. It operates as a B2B. The company has 1 employees. Denexopharma offers products and services including Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection.

  • Headquarter India
  • Employees 1 as on
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Denexo Pharmaceuticals Private Limited
  • Date of Incorporation 20 Apr, 2022
  • Jurisdiction Kharghar, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Denexopharma

Denexopharma offers a comprehensive portfolio of products and services, including Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection.

Product name locked
Category locked
Primary

Injections for treatments like antibiotics and cancer therapy.

Product name locked
Category locked
Locked

Tablets for conditions including antifungal and immunosuppressive uses.

Product name locked
Category locked
Locked

Capsules for therapies such as tacrolimus-based immunosuppression.

Product name locked
Category locked
Locked

Injection for bacterial infections and related treatments.

Product name locked
Category locked
Locked

Injection for blood clot prevention and management.

Funding Insights of Denexopharma

Premium access

Detailed funding history for Denexopharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Denexopharma

Investments
Premium access

Investment portfolio details for Denexopharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Denexopharma

Premium access

Detailed financials for Denexopharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Denexopharma Comparisons

Denexopharma Primary company
Description
Wholesaler and trader of pharmaceutical injections, tablets,...
Location
India
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
1
As of 2026
Premium access

Peer comparison for Denexopharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Denexopharma

Premium access

Detailed competitors of Denexopharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Denexopharma

Premium access

Complete news archive for Denexopharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Denexopharma

Denexopharma is headquartered in India.

As of the latest available data, the latest employee count at Denexopharma is 1.

Denexo Pharmaceuticals Private Limited, established in 2022, operates as a trader and wholesaler of various pharmaceutical products including injections, tablets, capsules, and related medical supplies. Based in Navi Mumbai, Maharashtra, India, they distribute these items to businesses in the healthcare sector, focusing on generic drugs and treatments. Their activities involve sourcing and supplying products for medical use, ensuring availability to distributors.

Denexopharma offers Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available